Institute for International Research

Know how to achieve

Main menu

My IIR

Login form

Sign Up

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200



Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Find another IIR Event

Event Search Form by Industry

Home»Events»BioAnalytical Method...Cell Based Assays- Co-Located

BioAnalytical Method Development BioAnalytical Method Development

October 06 - 08, 2008 | InterContinental San Francisco, San Francisco, CA

Cell Based Assays- Co-Located

Cell Based Assays- Co-Located

Cell Based Assays
in Drug Development for Biopharmaceuticals
InterContinental Hotel San Francisco, CA www.iirusa.com/cba


New Approaches & Methodologies for Development,Validation & Transfer of Cell Based Assays for:
  • Potency
  • Immunogenicity
  • Characterization
  • Immunotoxicology
  • In Vitro Toxicology
  • New Case Studies & Discussions of Novel Approaches & Methodologies for Development,Validation & Transfer of Cell Based Assays
Assay Development
  • How to improve the monitoring of bioassays
  • Measure anti-drug antibodies in the presence of drug
Assay Validation
  • Differentiate qualification vs. validation requirements
  • Use of DOE in validation robustness of potency assays
Potency Assessment
  • Challenges in the selection of a potency assay for lot release
  • Potency of a Monoclonal Antibody Product against a Cell Surface Receptor
Analysis
  • Correct analysis of biological assay data & parallel line analysis
  • Match sensitivity of cell based assay to ELISA like methods controlling sensitivity drift

Event Sponsors

  • Meso Scale Discovery (MSD)

Send To A Friend

Invite a colleague to join you at this event

Add Event To Calendar

Save the event dates in your Outlook calendar

Registration

Online Registration is open!

Bottom menu

Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved

Powered by Interactive Agency Janmedia Interactive, Inc.